Stem-cell research is the area of research that studies the properties of stem cells and their potential use in medicine. As stem cells are the source of all tissues, understanding their ...

or sickle cell anemia. But having sickle cell trait raises the risk of some health conditions. According to the American Society of Hematology, between 1 million and 3 million Americans have ...

People with sickle cell disease are immunocompromised, which means they have an increased risk of infection. For this reason, immunizations are an important part of complete sickle cell care. This ...

Around 3% to 9% are Hispanic or Latino. The most severe form of SCD is sickle cell anemia. If parents are considering having a child and are concerned about sickle cell trait, here are some steps ...

We have pulled together this FEH tier list, catered specifically to Arena battles, though each of the characters in this Fire Emblem Heroes tier list has a lot of utility across all game modes. Keep ...

President Bola Tinubu on Tuesday launched the 2025 Armed Forces of Nigeria Remembrance Day emblem and appeal fund. Launching the emblem at the Council Chamber in the State House in Abuja ...

Hemolytic anemia describes a large group of conditions characterized by accelerated destruction of red blood cells. The average lifespan of a red blood cell is 120 days. At the end of 120 days, the ...

The present study includes a review of this subject and a report of a patient with sickle-cell anemia in whom documentation of folic acid deficiency was obtained and the response to "minute" or ...

Learn about sickle cell anemia in African Americans. Because sickle cell disease is genetic, a person cannot prevent it after conception. However, people can take steps to prevent passing on the ...

Editas Medicine said Tuesday it will license out or partner its lead sickle cell treatment, the latest shift for a tarantella company that has repeatedly switched direction and leadership since ...

“The initiation of this study reaffirms hope for the 20 million sickle cell-affected patients in the country for a high potential novel treatment.” Desidustat is approved in India under the name ...

A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct. 21. Kendric Cromer began treatment with Bluebird bio's ...